ES2487513T3 - Composición nutracéutica y métodos de uso - Google Patents

Composición nutracéutica y métodos de uso Download PDF

Info

Publication number
ES2487513T3
ES2487513T3 ES08860286.7T ES08860286T ES2487513T3 ES 2487513 T3 ES2487513 T3 ES 2487513T3 ES 08860286 T ES08860286 T ES 08860286T ES 2487513 T3 ES2487513 T3 ES 2487513T3
Authority
ES
Spain
Prior art keywords
methods
nutraceutical composition
cartilage
composition
stimulating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES08860286.7T
Other languages
English (en)
Inventor
Dan Bright
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dacy Tech Pty Ltd
Original Assignee
Dacy Tech Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2007906770A external-priority patent/AU2007906770A0/en
Application filed by Dacy Tech Pty Ltd filed Critical Dacy Tech Pty Ltd
Application granted granted Critical
Publication of ES2487513T3 publication Critical patent/ES2487513T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13—Coniferophyta (gymnosperms)
    • A61K36/14—Cupressaceae (Cypress family), e.g. juniper or cypress
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Rheumatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Composición que comprende una cantidad terapéutica de un extracto de una planta Biota orientalis para su uso en el tratamiento de degradación de cartílago en un organismo, estimulando el crecimiento o la reparación de cartílago a través de la estimulación de la proliferación de condrocitos.

Description

imagen1
imagen2
imagen3
imagen4
imagen5
imagen6
imagen7
imagen8
imagen9
imagen10
imagen11
imagen12
imagen13
imagen14
imagen15

Claims (1)

  1. imagen1
ES08860286.7T 2007-12-12 2008-12-12 Composición nutracéutica y métodos de uso Active ES2487513T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2007906770 2007-12-12
AU2007906770A AU2007906770A0 (en) 2007-12-12 Nutraceutical composition and methods of use
PCT/AU2008/001833 WO2009073930A1 (en) 2007-12-12 2008-12-12 Nutraceutical composition and methods of use

Publications (1)

Publication Number Publication Date
ES2487513T3 true ES2487513T3 (es) 2014-08-21

Family

ID=40755187

Family Applications (1)

Application Number Title Priority Date Filing Date
ES08860286.7T Active ES2487513T3 (es) 2007-12-12 2008-12-12 Composición nutracéutica y métodos de uso

Country Status (11)

Country Link
US (1) US8431169B2 (es)
EP (1) EP2231173B1 (es)
KR (1) KR101628234B1 (es)
CN (1) CN101945661B (es)
AU (1) AU2008336267B2 (es)
CA (1) CA2714399C (es)
DK (1) DK2231173T3 (es)
ES (1) ES2487513T3 (es)
NZ (1) NZ586722A (es)
WO (1) WO2009073930A1 (es)
ZA (1) ZA201004893B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012020999A (ja) * 2010-07-16 2012-02-02 Dacy Tech Pty Ltd 軟骨の劣化の治療のための医薬
WO2016090262A1 (en) 2014-12-05 2016-06-09 Shire Human Genetic Therapies, Inc. Messenger rna therapy for treatment of articular disease

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4473551A (en) * 1982-08-23 1984-09-25 Faxon Pharmaceuticals, Inc. Anti-inflammatory composition
JPS60193996A (ja) * 1984-03-14 1985-10-02 Hokuriku Seiyaku Co Ltd 側柏葉から止血活性物質を抽出する方法、及びそれを含有する止血剤
JPH0725761A (ja) * 1993-07-09 1995-01-27 Kureha Chem Ind Co Ltd 軟骨保護剤
AUPM740594A0 (en) * 1994-08-11 1994-09-01 J.W. Broadbent Nominees Pty. Ltd. Anti-inflammatory preparation
US20040044028A1 (en) * 2001-03-30 2004-03-04 Obukowicz Mark G. Combinations of omega-3 fatty acids and cyclooxygenase-2 inhibitors for treatment or prevention of cardiovascular disease and treatment or prevention of cancer
EP1450835B1 (en) * 2001-12-07 2006-09-20 Randy H. Ziegler Compositions for the treatment of lupus
KR20040015917A (ko) * 2002-08-14 2004-02-21 에스케이케미칼주식회사 여드름 예방 및 치료용 피부외용제 조성물
GB0307989D0 (en) * 2003-04-07 2003-05-14 Mcewen Lab Ltd Therapeutic composition
KR20060016163A (ko) * 2004-08-17 2006-02-22 주식회사 알파인프로덕트 탈모방지 및 발모/육모촉진제
CN1899527A (zh) * 2006-07-20 2007-01-24 贾俊华 减脂祛风火疗液

Also Published As

Publication number Publication date
CN101945661A (zh) 2011-01-12
KR20100124246A (ko) 2010-11-26
DK2231173T3 (da) 2014-07-21
AU2008336267B2 (en) 2013-07-18
CA2714399C (en) 2018-07-24
WO2009073930A1 (en) 2009-06-18
US8431169B2 (en) 2013-04-30
AU2008336267A1 (en) 2009-06-18
EP2231173A4 (en) 2011-09-07
CA2714399A1 (en) 2009-06-18
US20100297254A1 (en) 2010-11-25
EP2231173B1 (en) 2014-05-14
EP2231173A1 (en) 2010-09-29
NZ586722A (en) 2013-01-25
KR101628234B1 (ko) 2016-06-08
ZA201004893B (en) 2011-05-25
CN101945661B (zh) 2014-03-12

Similar Documents

Publication Publication Date Title
ES2524458T3 (es) DNasa para el tratamiento de la subfertilidad masculina
ES2540751T3 (es) Composición para mejorar la función sexual masculina que contiene extracto de baya de ginseng
ES2552651T3 (es) Composición inyectable de polidesoxirribonucleótido para el tratamiento de enfermedades osteoarticulares
ES2602986T3 (es) Nuevas composiciones cosméticas y/o farmacológicas y sus aplicaciones
CL2010000188A1 (es) Metodo para el tratamiento de una infeccion en un sujeto que comprende la administracion de 9-[(2,2-dimetil-propilamino)-metil]-minociclina o de una sal de la misma; composicion farmaceutica que comprende dicho compuesto; y su uso.
ES2488407T3 (es) Preparación farmacéutica que contiene lipasa de origen bacteriano
UY27720A1 (es) Aroilpiridinonas monocíclicas,
ECSP11010975A (es) Método de uso de una cepa de bacillus subtilis para mejorar la salud de animales
CL2012001950A1 (es) Uso de una cepa bacteriana probiotico en la fabricacion de un medicamento o composicion nutricional en humanos o animales para alterar los patrones del sueño
AR059390A1 (es) Uso de flibanserina para el tratamiento de trastornos del deseo sexual premenopausicos
BRPI0811816A2 (pt) "forma de dosagem de picoplatina estabilizada, método para preparar uma forma de dosagem de picoplatina estabilizada, composições, kit, pluralidade de kits, método para tratamento de câncer e uso de uma quantidade eficaz da forma de dosagem"
CR11135A (es) Dispositivos para el implante de una valvula de corazon prostetica y cierre de acceso por medio de cateter
CL2011000527A1 (es) Compuestos derivados de benzofurano; composicion farmaceutica que los comprende;y su uso en el tratamiento de la hepatitis c.
EP1736824A3 (en) Photosensitive composition, compound for use in the photosensitive composition and pattern forming method using the photosensitive composition
CL2008001633A1 (es) Compuestos derivados de pirrolidin-3-carboxamida; composición farmacéutica; y uso comominhibidores de erk para el tratamiento del cancer.
CL2008002381A1 (es) Oligonucleotido inmunoestimulador; composicion farmaceutica que lo comprende; y su uso para tratar un trastorno o afeccion en un sujeto, incluyendo cancer.
WO2014046753A3 (en) Method and system for treatment of biological tissue
CL2007002384A1 (es) Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento de la psoriasis.
CL2009000309A1 (es) Derivados fluoroglicosidos aromaticos, composicion farmaceutica que contenga estos compuestos, procedimiento para prepararla y su uso en el tratamiento de la diabetes tipo 1 y 2.
CL2007002380A1 (es) Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento terapeutico y/o profilactico de la queratosis actinica.
BRPI0919013A2 (pt) Dispositivo e sistema de implante pélvico
ITTO20040390A1 (it) Composizione, in particolare per uso farmaceutico, ad azione antiossidante, antinfiammatoria ed immunostimolante.
MX2014000066A (es) Formulaciones mucoadhesivas en gel de alta dosificación de metronidazol de base acuosa y su uso para tratar la vaginosis bacteriana.
ES2531516T3 (es) Uso de escina
GT200600115A (es) Metodo para identificar blancos terapeuticos para el tratamiento de atrofia vulvoginal